Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125503621 | 12550362 | 1 | I | 2009 | 20160706 | 20160712 | 20160712 | EXP | US-PFIZER INC-2016334042 | PFIZER | 57.00 | YR | F | Y | 77.00000 | KG | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125503621 | 12550362 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 2X/DAY | Y | L75541 | 21446 | 200 | MG | CAPSULE, HARD | BID | ||||
| 125503621 | 12550362 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 2X/DAY | Y | M57606 | 21446 | 100 | MG | CAPSULE, HARD | BID | ||||
| 125503621 | 12550362 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, 2X/DAY | G509422 | 0 | 60 | MG | CAPSULE | BID | |||||
| 125503621 | 12550362 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, 1X/DAY EVERY MORNING | 0 | 10 | MG | TABLET | QD | ||||||
| 125503621 | 12550362 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | CAPSULE | BID | ||||||
| 125503621 | 12550362 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 20 MG, 1X/DAY AT BEDTIME | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125503621 | 12550362 | 1 | Post herpetic neuralgia |
| 125503621 | 12550362 | 3 | Post herpetic neuralgia |
| 125503621 | 12550362 | 4 | Hypertension |
| 125503621 | 12550362 | 5 | Gastrooesophageal reflux disease |
| 125503621 | 12550362 | 6 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125503621 | 12550362 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125503621 | 12550362 | Agitation | |
| 125503621 | 12550362 | Ankle fracture | |
| 125503621 | 12550362 | Condition aggravated | |
| 125503621 | 12550362 | Disturbance in attention | |
| 125503621 | 12550362 | Drug intolerance | |
| 125503621 | 12550362 | Dysphagia | |
| 125503621 | 12550362 | Fall | |
| 125503621 | 12550362 | Gastritis | |
| 125503621 | 12550362 | Gastrooesophageal reflux disease | |
| 125503621 | 12550362 | Hyperhidrosis | |
| 125503621 | 12550362 | Impaired work ability | |
| 125503621 | 12550362 | Impulsive behaviour | |
| 125503621 | 12550362 | Nervousness | |
| 125503621 | 12550362 | Personality change | |
| 125503621 | 12550362 | Tachyphrenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125503621 | 12550362 | 1 | 2009 | 0 | ||
| 125503621 | 12550362 | 2 | 2015 | 0 | ||
| 125503621 | 12550362 | 3 | 2009 | 0 |